دورية أكاديمية
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
العنوان: | Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial |
---|---|
المؤلفون: | Li, RogerAff1, Aff2, IDs41591024031576_cor1, Shah, Paras H., Stewart, Tyler F., Nam, Jong Kil, Bivalacqua, Trinity J., Lamm, Donald L., Uchio, Edward M., Geynisman, Daniel M., Jacob, Joseph M., Meeks, Joshua J., Dickstein, Rian, Pearce, Shane M., Kang, Seok Ho, Jung, Seung Il, Kamat, Ashish M., Burke, James M., Keegan, Kirk A.Aff18, Aff19, Steinberg, Gary D. |
المصدر: | Nature Medicine. 30(8):2377-2377 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 10788956 1546170X |
---|---|
DOI: | 10.1038/s41591-024-03157-6 |